X-136207829-C-G

Variant names:

• chrX-136207829-C-G
• rs267606813
• NM_001159702.3:c.369C>G

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2 PP3_Strong PP5_Moderate

The NM_001159699.2(FHL1):​c.417C>G​(p.His139Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

• Frequency: Genomes: not found (cov: 23)
• Consequence: FHL1 NM_001159699.2 missense
• Clinical Significance: Pathogenic criteria provided, single submitter P:2
• Conservation: PhyloP100: 0.177

Genes affected

FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]

ACMG classification

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.991
• PP5: Variant X-136207829-C-G is Pathogenic according to our data. Variant chrX-136207829-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 11562.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
FHL1	NM_001159702.3	c.369C>G	p.His123Gln	missense_variant	Exon 5 of 8	ENST00000394155.8	NP_001153174.1
FHL1	NM_001159699.2	c.417C>G	p.His139Gln	missense_variant	Exon 4 of 6	ENST00000370683.6	NP_001153171.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
FHL1	ENST00000394155.8	c.369C>G	p.His123Gln	missense_variant	Exon 5 of 8	5	NM_001159702.3	ENSP00000377710.2
FHL1	ENST00000370683.6	c.417C>G	p.His139Gln	missense_variant	Exon 4 of 6	1	NM_001159699.2	ENSP00000359717.1

Frequencies

GnomAD3 genomes Cov.: 23

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 23

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:2

Revision: criteria provided, single submitter

Submissions by phenotype

Myopathy, reducing body, X-linked, early-onset, severe Pathogenic:1

Feb 01, 2009

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

X-linked myopathy with postural muscle atrophy Pathogenic:1

Nov 16, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant disrupts the p.His123 amino acid residue in FHL1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18274675, 19181672, 20633900, 24634512). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 11562). This missense change has been observed in individual(s) with X-linked dominant reducing body myopathy (PMID: 19181672). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 123 of the FHL1 protein (p.His123Gln). -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	1.0
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Pathogenic	0.66
CADD	Uncertain	24
DANN	Uncertain	0.99
DEOGEN2	Pathogenic	0.95	.;D;.;D;.;D;D;D;.;.;D;.;D;.;.;D;.;D;D;.;.;.;D;D;.
FATHMM_MKL	Uncertain	0.85	D
LIST_S2	Uncertain	0.91	.;D;.;D;D;D;D;D;D;.;.;.;D;.;D;D;D;D;.;.;D;D;T;D;.
M_CAP	Pathogenic	0.82	D
MetaRNN	Pathogenic	0.99	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM	Pathogenic	0.99	D
MutationAssessor	Pathogenic	4.2	H;H;H;.;H;.;.;.;.;H;.;H;.;H;H;.;.;.;H;.;.;.;.;.;H
PrimateAI	Uncertain	0.64	T
PROVEAN	Pathogenic	-7.8	.;D;D;.;.;D;D;.;.;.;D;D;D;D;D;D;.;D;D;.;D;D;D;D;.
REVEL	Pathogenic	0.91
Sift	Pathogenic	0.0	.;D;D;.;.;D;D;.;.;.;D;D;D;D;D;D;.;D;D;.;D;D;D;D;.
Sift4G	Uncertain	0.0020	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen		1.0, 1.0	.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;.;D;.;.
Vest4		0.96
MutPred		0.96		Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);.;.;.;Gain of catalytic residue at H123 (P = 0.0191);Gain of catalytic residue at H123 (P = 0.0191);
MVP		1.0
MPC		1.4
ClinPred		1.0	D
GERP RS		2.4
Varity_R		0.98

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs267606813; hg19: chrX-135289988;